[go: up one dir, main page]

MX2017003949A - Derivados peptidicos novedosos y sus usos. - Google Patents

Derivados peptidicos novedosos y sus usos.

Info

Publication number
MX2017003949A
MX2017003949A MX2017003949A MX2017003949A MX2017003949A MX 2017003949 A MX2017003949 A MX 2017003949A MX 2017003949 A MX2017003949 A MX 2017003949A MX 2017003949 A MX2017003949 A MX 2017003949A MX 2017003949 A MX2017003949 A MX 2017003949A
Authority
MX
Mexico
Prior art keywords
peptidic derivatives
new peptidic
new
derivatives
compositions
Prior art date
Application number
MX2017003949A
Other languages
English (en)
Other versions
MX383460B (es
Inventor
VILLAIN-GUILLOT Philippe
Gualtieri Maxime
RACINE Emilie
Original Assignee
Nosopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nosopharm filed Critical Nosopharm
Publication of MX2017003949A publication Critical patent/MX2017003949A/es
Publication of MX383460B publication Critical patent/MX383460B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención proporciona derivados novedosos de péptidos y composiciones que comprenden los mismos; la invención proporciona además métodos de tratamiento que comprenden administrar derivados novedosos de péptidos y/o composiciones que comprenden los mismos.
MX2017003949A 2014-09-26 2015-09-25 Derivados peptidicos novedosos y sus usos. MX383460B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14306504 2014-09-26
PCT/EP2015/072185 WO2016046409A1 (en) 2014-09-26 2015-09-25 Novel peptide derivatives and uses thereof

Publications (2)

Publication Number Publication Date
MX2017003949A true MX2017003949A (es) 2018-01-12
MX383460B MX383460B (es) 2025-03-13

Family

ID=51663118

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003949A MX383460B (es) 2014-09-26 2015-09-25 Derivados peptidicos novedosos y sus usos.

Country Status (13)

Country Link
US (1) US10626144B2 (es)
EP (1) EP3197908A1 (es)
JP (2) JP7123559B2 (es)
KR (1) KR102522224B1 (es)
CN (1) CN106715460B (es)
AU (1) AU2015323713B2 (es)
BR (1) BR112017005993A2 (es)
CA (1) CA2961297C (es)
IL (1) IL251289B (es)
MA (1) MA40642A (es)
MX (1) MX383460B (es)
RU (1) RU2699572C2 (es)
WO (1) WO2016046409A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX383460B (es) * 2014-09-26 2025-03-13 Nosopharm Derivados peptidicos novedosos y sus usos.
CN113185549A (zh) * 2021-04-30 2021-07-30 河北农业大学 一种Wittig-Horner试剂的制备方法
WO2024200838A1 (en) 2023-03-31 2024-10-03 Nosopharm New odilorhabdins analogues as antibiotics against multi-resistant bacteria

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1451623A (fr) 1964-09-29 1966-01-07 Associated Semiconductor Mft Procédé d'application d'une couche de bioxyde de germanium tétragonal sur un corps de germanium
JP2003509465A (ja) 1999-07-19 2003-03-11 エピミューン, インコーポレイテッド ペプチドおよび核酸組成物を使用する、c型肝炎ウイルスに対する細胞性免疫応答の誘導
US20090325312A1 (en) 2006-05-12 2009-12-31 Ailan Guo Reagens for the detection of protein acetylation signaling pathways
WO2009106073A2 (en) * 2008-02-28 2009-09-03 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
JP6158188B2 (ja) 2011-09-28 2017-07-05 ノソファルムNosopharm 抗生物質としての新規なペプチド誘導体
US9745581B2 (en) 2012-05-16 2017-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of treating and diagnosing diseases using agents that regulate the alternative splicing pathway
MX383460B (es) 2014-09-26 2025-03-13 Nosopharm Derivados peptidicos novedosos y sus usos.

Also Published As

Publication number Publication date
IL251289B (en) 2021-02-28
CA2961297C (en) 2024-06-04
CN106715460B (zh) 2022-04-08
KR20170057400A (ko) 2017-05-24
BR112017005993A2 (pt) 2017-12-19
MX383460B (es) 2025-03-13
AU2015323713A1 (en) 2017-04-20
KR102522224B1 (ko) 2023-04-14
MA40642A (fr) 2016-03-31
WO2016046409A1 (en) 2016-03-31
JP2021100939A (ja) 2021-07-08
CA2961297A1 (en) 2016-03-31
US10626144B2 (en) 2020-04-21
RU2017112510A (ru) 2018-11-01
CN106715460A (zh) 2017-05-24
EP3197908A1 (en) 2017-08-02
RU2699572C2 (ru) 2019-09-06
AU2015323713B2 (en) 2020-04-23
IL251289A0 (en) 2017-05-29
US20170298097A1 (en) 2017-10-19
RU2017112510A3 (es) 2019-02-25
JP7123559B2 (ja) 2022-08-23
JP2017533890A (ja) 2017-11-16

Similar Documents

Publication Publication Date Title
CY1124215T1 (el) Μκ2 αναστολεις και χρησεις αυτων
CY1122803T1 (el) Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
MX387587B (es) Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos.
MX2022003273A (es) Anticuerpos anti-tau y metodos de uso.
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
MX380146B (es) Inhibidores mk2 y usos de los mismos.
CY1123622T1 (el) Τροποποιημενα μηνιγγιτιδοκοκκικα fhbp πολυπεπτιδια
MX2017000395A (es) Vacunas contra virus influenza y usos de las mismas.
MX2016009625A (es) Proteinas quimericas tipo fosfatasa alcalina.
MX375352B (es) Reguladores de nrf2.
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
MY176855A (en) Anti-jagged1 antibodies and methods of use
MX389001B (es) Moduladores de interacción de sestrina-gator2 y sus usos.
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
MX378904B (es) Vacunas para virus influenza y usos de las mismas.
MX395231B (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos.
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
MX377774B (es) Formulaciones de proteinas.
DOP2018000034A (es) Combinaciones de un anticuerpo ox40 y un modulador de tlr4 y usos de las mismas
CO2018008249A2 (es) Composiciones terapéuticas y métodos para el tratamiento de la hepatitis b
ECSP17074919A (es) Piroglutamato de vortioxetina
BR112018077458A2 (pt) proteases aspárticas
MX2017013729A (es) Deteccion especifica de isoformas de clusterina.